SCHEMBL1824914

SCHEMBL1824914

CC(C)(C)OC(=O)[C@H](Cc1ccc(OS(=O)(=O)c2ccccc2)cc1)NC(=O)OCc1ccccc1

nearest known ligand 0.68

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 17/20 0.68
BCL2 P10415 1/20 0.54
ITGB3 P05106 2/20 0.52
ITGA2B P08514 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1824913 1.00 P2RX7 (0.68) P2RX7BCL2ITGB3ITGA2B
SCHEMBL3580936 0.94 P2RX7 (0.76) P2RX7ITGB3ITGA2B
SCHEMBL3580935 0.94 P2RX7 (0.76) P2RX7ITGB3ITGA2B
SCHEMBL1824451 0.92 P2RX7 (0.63) P2RX7BCL2
SCHEMBL1824453 0.92 P2RX7 (0.63) P2RX7BCL2
SCHEMBL1825289 0.92 P2RX7 (0.57) P2RX7BCL2ITGB3ITGA2B
SCHEMBL1825287 0.92 P2RX7 (0.57) P2RX7BCL2ITGB3ITGA2B
SCHEMBL1824760 0.90 P2RX7 (0.57) P2RX7BCL2
SCHEMBL1826579 0.90 P2RX7 (0.58) P2RX7BCL2ITGB3ITGA2B
SCHEMBL1826580 0.90 P2RX7 (0.58) P2RX7BCL2ITGB3ITGA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2161254-B1 Intermediate for preparing a biaryl compound SUMITOMO CHEMICAL CO (JP) 2014-08-13 EP disclosed
EP-1481967-B1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS SUMITOMO CHEMICAL CO (JP) 2011-05-04 EP disclosed
US-7714157-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-05-11 US disclosed
EP-2161254-A1 Intermediate for preparing a biaryl compound Sumitomo Chemical Company, Limited (JP) 2010-03-10 EP disclosed
US-20070270603-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2007-11-22 US disclosed
US-7271280-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-18 US disclosed
EP-1481967-A1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS Sumitomo Chemical Company, Limited (JP) 2004-12-01 EP disclosed
US-20040158093-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040158093-A1 Process for preparing a biaryl compound CYP1B1, REL, CYP2F1 P2RX7 3606/4885BCL2 1414/4885ITGB3 2686/4885
US-20070270603-A1 Process for preparing a biaryl compound CYP4A11, CYP4B1, CYP51A1 P2RX7 2747/4885BCL2 1908/4885ITGB3 4493/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.